Summary
Lu Chen is a statistical analyst and SAS programmer with eight years of experience applying biostatistics and real-world evidence methods across pharma and public health settings. Currently supporting Cardio-Metabolic Medical Affairs at Eli Lilly, she brings hands-on SAS development for SDTM/ADaM, TLFs, and RWE analyses that have informed regulatory submissions and peer-reviewed work. Lu has co-led Phase IV programs at Amgen and produced RWE cohorts and publications using MarketScan data, demonstrating an ability to translate complex protocols into validated, reproducible analytics. Trained in biostatistics and nutrition (MPH and MS), she pairs domain knowledge in epidemiology and clinical research with meticulous QC and cross-team communication. Notably, her background spans bench-to-bureaucracy research—from NIH- and ADA-funded lab projects to state health surveillance—giving her a rare perspective on both mechanistic and population-level health evidence.
8 years of coding experience
8 years of employment as a software developer
Master of Public Health - MPH, Biostatistics, Master of Public Health - MPH, Biostatistics at Texas A&M University
University of Missouri